CIK 0000882095 · Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943047598
- Phone
- 6505743000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $35,234,659
- in 11 filings, $35.2M under 10b5-1 plans
Net −$35,234,659. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- O'Day Daniel Patrick −$29.5M Chairman & CEO sold 24% of stake
- WELTERS ANTHONY −$2.7M Director sold 58% of stake
- Dickinson Andrew D −$905K Chief Financial Officer sold 4% of stake
- Mercier Johanna −$901K Chief Comm & Corp Aff Officer sold 5% of stake
- Bluestone Jeffrey −$725K Director sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-10 | Dickinson Andrew D Chief Financial Officer | Grant or award · Non-qualified Stock Option (Right to Buy) | +35,880 | 35,880 | ||
| 2026-02-27 | Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | Grant or award | +470 | 4,414 | ||
| 2026-02-27 | Mercier Johanna Chief Comm & Corp Aff Officer | Grant or award | +11,090 | 131,378 | ||
| 2026-02-27 | Berger Dietmar Chief Medical Officer | Grant or award | +8,530 | 17,912 | ||
| 2026-02-27 | O'Day Daniel Patrick Chairman & CEO | Grant or award 10b5-1 | +38,396 | 652,308 | ||
| 2026-02-27 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −3,481 | $144.04 | $501K | 648,827 |
| 2026-02-27 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −6,419 | $145.18 | $932K | 642,408 |
| 2026-02-27 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −100 | $145.71 | $15K | 642,308 |
| 2026-02-27 | Dickinson Andrew D Chief Financial Officer | Grant or award | +11,090 | 178,869 | ||
| 2026-02-17 | Mercier Johanna Chief Comm & Corp Aff Officer | Option exercise 10b5-1 | +25,000 | $66.64 | $1.7M | 148,288 |
| 2026-02-17 | Mercier Johanna Chief Comm & Corp Aff Officer | Sale 10b5-1 | −18,405 | $154.18 | $2.8M | 129,883 |
| 2026-02-17 | Mercier Johanna Chief Comm & Corp Aff Officer | Sale 10b5-1 | −9,395 | $154.91 | $1.5M | 120,488 |
| 2026-02-17 | Mercier Johanna Chief Comm & Corp Aff Officer | Sale 10b5-1 | −200 | $155.62 | $31K | 120,288 |
| 2026-02-17 | Mercier Johanna Chief Comm & Corp Aff Officer | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −25,000 | 48,110 | ||
| 2026-02-17 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −3,000 | $154.43 | $463K | 167,779 |
| 2026-02-05 | O'Day Daniel Patrick Chairman & CEO | Option exercise 10b5-1 | +115,640 | $66.01 | $7.6M | 729,552 |
| 2026-02-05 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −115,640 | $150.00 | $17.3M | 613,912 |
| 2026-02-05 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −115,640 | 0 | ||
| 2026-02-03 | Mercier Johanna Chief Comm & Corp Aff Officer | Grant or award | +44,867 | 148,088 | ||
| 2026-02-03 | Mercier Johanna Chief Comm & Corp Aff Officer | Shares withheld for taxes | −24,800 | $143.28 | $3.6M | 123,288 |
Page 9 of 30 · 584 trades